SIRT3 and triple-negative breast carcinoma: SIRT3 could be mediated by metadherin (MTDH) to enhance its activity, and enhance EMT and invasion by participating in the NFκB/SIRT3/MnSOD pathway, ultimately promoting the metastasis and spread of triple-negative breast cancer (83) (Figure 3B).